Skip to main content
Premium Trial:

Request an Annual Quote

Hologic/Gen-Probe Posts $1.88B in Pro Forma Revenues Through First Nine Months of Fiscal 2012

NEW YORK (GenomeWeb News) – The combined businesses of Hologic and Gen-Probe posted $1.88 billion in revenues through the first nine months of Fiscal Year 2012 on a pro forma basis, Hologic said after the close of the market on Monday.

In a document filed with the US Securities and Exchange Commission, Hologic said that it had $1.41 billion in revenues, while Gen-Probe had $467.6 million in revenues through June 23, 2012. Bedford, Mass.-based Hologic, which acquired Gen-Probe for $3.8 billion in August, ended its fiscal year in late September and is scheduled to announce its fiscal fourth-quarter and full fiscal-year 2012 earnings results on Nov. 12.

For the first nine months of fiscal 2012, the combined company had a net loss of $102.1 million, or $.39 per share, on a pro forma basis. R&D costs totaled $170.5 million, and SG&A costs were $463.2 million.

Reporting as if Gen-Probe were part of Hologic in full Fiscal Year 2011 ended Sept. 24, 2011, Hologic said that revenues for the combined company were $2.37 billion on a pro forma basis. Hologic had $1.79 billion in revenues and Gen-Probe had $576.2 million in revenues.

The combined firm's net loss was $23.8 million, or $.09 per share.

Its R&D expenses were $231.6 million, while SG&A costs were $575.9 million.

The combined firm exited the quarter ended June 23, 2012 with $471.6 million in cash and cash equivalents on a pro forma basis.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.